# Peter van der Meer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-van-der-meer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,408 |
| Field | Heart Failure Treatment and Management |
| h-index | 71 |
| i10-index | 181 |
| Last Known Institution | University Medical Center Groningen |
| OpenAlex ID | https://openalex.org/A5105820804 |
| ORCID iD | 0000-0002-9705-4413 |
| Works | 288 |

## Researcher papers

Showing 12 of 14.

- [2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)](https://scholariq.org/papers/2022-esc-guidelines-on-cardio-oncology-developed-in-collaboration-with-the-2/)
- [Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and/)
- [Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial](https://scholariq.org/papers/ferric-carboxymaltose-for-iron-deficiency-at-discharge-after-acute-heart-failure/)
- [Iron deficiency in chronic heart failure: An international pooled analysis](https://scholariq.org/papers/iron-deficiency-in-chronic-heart-failure-an-international-pooled-analysis/)
- [Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes](https://scholariq.org/papers/semaglutide-in-patients-with-obesity-related-heart-failure-and-type-2-diabetes/)
- [Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy](https://scholariq.org/papers/pathophysiology-diagnosis-and-management-of-peripartum-cardiomyopathy-a-position/)
- [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2016-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart/)
- [Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency](https://scholariq.org/papers/effect-of-ferric-carboxymaltose-on-exercise-capacity-in-patients-with-chronic/)
- [Empagliflozin after Acute Myocardial Infarction](https://scholariq.org/papers/empagliflozin-after-acute-myocardial-infarction/)
- [Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study](https://scholariq.org/papers/identifying-optimal-doses-of-heart-failure-medications-in-men-compared-with/)
- [Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial](https://scholariq.org/papers/patiromer-for-the-management-of-hyperkalemia-in-heart-failure-with-reduced/)
- [Signature of Circulating microRNAs in Patients with Acute Heart Failure](https://scholariq.org/papers/signature-of-circulating-micrornas-in-patients-with-acute-heart-failure/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

## Researcher university

- [University Medical Center Groningen](https://scholariq.org/institutions/university-medical-center-groningen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.